{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T20:31:11Z","timestamp":1775161871849,"version":"3.50.1"},"reference-count":55,"publisher":"Portland Press Ltd.","issue":"6","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,12,1]]},"abstract":"<jats:p>ALS (amyotrophic lateral sclerosis), a fatal motoneuron (motor neuron) disease, occurs in clinically indistinguishable sporadic (sALS) or familial (fALS) forms. Most fALS-related mutant proteins identified so far are prone to misfolding, and must be degraded in order to protect motoneurons from their toxicity. This process, mediated by molecular chaperones, requires proteasome or autophagic systems. Motoneurons are particularly sensitive to misfolded protein toxicity, but other cell types\u00a0such as the muscle cells could also be affected. Muscle-restricted expression of the fALS protein mutSOD1 (mutant superoxide dismutase 1) induces muscle atrophy and motoneuron death. We found that several genes have an altered expression in muscles of transgenic ALS mice at different stages of disease. MyoD, myogenin, atrogin-1, TGF\u03b21 (transforming growth factor \u03b21) and components of the cell response to proteotoxicity [HSPB8 (heat shock 22kDa protein 8), Bag3 (Bcl-2-associated athanogene 3) and p62] are all up-regulated by mutSOD1 in skeletal muscle. When we compared the potential mutSOD1 toxicity in motoneuron (NSC34) and muscle (C2C12) cells, we found that muscle ALS models possess much higher chymotryptic proteasome activity and autophagy power than motoneuron ALS models. As a result, mutSOD1 molecular behaviour was found to be very different. MutSOD1 clearance was found to be much higher in muscle than in motoneurons. MutSOD1 aggregated and impaired proteasomes only in motoneurons, which were particularly sensitive to superoxide-induced oxidative stress. Moreover, in muscle cells, mutSOD1 was found to be soluble even after proteasome inhibition. This effect could be associated with a higher mutSOD1 autophagic clearance. Therefore muscle cells seem to manage misfolded mutSOD1 more efficiently than motoneurons, thus mutSOD1 toxicity in muscle may not directly depend on aggregation.<\/jats:p>","DOI":"10.1042\/bst20130118","type":"journal-article","created":{"date-parts":[[2015,8,11]],"date-time":"2015-08-11T16:49:03Z","timestamp":1439311743000},"page":"1598-1604","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Motoneuronal and muscle-selective removal of ALS-related misfolded proteins"],"prefix":"10.1042","volume":"41","author":[{"given":"Valeria","family":"Crippa","sequence":"first","affiliation":[{"name":"Sezione di Biomedicina e Endocrinologia, Dipartimento di Scienze Farmacologiche e Biomolecolari (DiSFeB), Centro di Eccellenza sulle Malattie Neurodegenerative, Universit\u00e0 degli Studi di Milano, 20133 Milan, Italy"},{"name":"Centro InterUniversitario sulle Malattie Neurodegenerative, Universit\u00e0 degli Studi di Firenze, Milano, Genova e Roma Tor Vergata"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariarita","family":"Galbiati","sequence":"additional","affiliation":[{"name":"Sezione di Biomedicina e Endocrinologia, Dipartimento di Scienze Farmacologiche e Biomolecolari (DiSFeB), Centro di Eccellenza sulle Malattie Neurodegenerative, Universit\u00e0 degli Studi di Milano, 20133 Milan, Italy"},{"name":"Centro InterUniversitario sulle Malattie Neurodegenerative, Universit\u00e0 degli Studi di Firenze, Milano, Genova e Roma Tor Vergata"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Boncoraglio","sequence":"additional","affiliation":[{"name":"Sezione di Biomedicina e Endocrinologia, Dipartimento di Scienze Farmacologiche e Biomolecolari (DiSFeB), Centro di Eccellenza sulle Malattie Neurodegenerative, Universit\u00e0 degli Studi di Milano, 20133 Milan, Italy"},{"name":"Centro InterUniversitario sulle Malattie Neurodegenerative, Universit\u00e0 degli Studi di Firenze, Milano, Genova e Roma Tor Vergata"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Rusmini","sequence":"additional","affiliation":[{"name":"Sezione di Biomedicina e Endocrinologia, Dipartimento di Scienze Farmacologiche e Biomolecolari (DiSFeB), Centro di Eccellenza sulle Malattie Neurodegenerative, Universit\u00e0 degli Studi di Milano, 20133 Milan, Italy"},{"name":"Centro InterUniversitario sulle Malattie Neurodegenerative, Universit\u00e0 degli Studi di Firenze, Milano, Genova e Roma Tor Vergata"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Onesto","sequence":"additional","affiliation":[{"name":"Dipartimento di Neurologia e Laboratorio di Neuroscienze, IRCCS Istituto Auxologico Italiano, 20133 Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Giorgetti","sequence":"additional","affiliation":[{"name":"Sezione di Biomedicina e Endocrinologia, Dipartimento di Scienze Farmacologiche e Biomolecolari (DiSFeB), Centro di Eccellenza sulle Malattie Neurodegenerative, Universit\u00e0 degli Studi di Milano, 20133 Milan, Italy"},{"name":"Centro InterUniversitario sulle Malattie Neurodegenerative, Universit\u00e0 degli Studi di Firenze, Milano, Genova e Roma Tor Vergata"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Cristofani","sequence":"additional","affiliation":[{"name":"Sezione di Biomedicina e Endocrinologia, Dipartimento di Scienze Farmacologiche e Biomolecolari (DiSFeB), Centro di Eccellenza sulle Malattie Neurodegenerative, Universit\u00e0 degli Studi di Milano, 20133 Milan, Italy"},{"name":"Centro InterUniversitario sulle Malattie Neurodegenerative, Universit\u00e0 degli Studi di Firenze, Milano, Genova e Roma Tor Vergata"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arianna","family":"Zito","sequence":"additional","affiliation":[{"name":"Sezione di Biomedicina e Endocrinologia, Dipartimento di Scienze Farmacologiche e Biomolecolari (DiSFeB), Centro di Eccellenza sulle Malattie Neurodegenerative, Universit\u00e0 degli Studi di Milano, 20133 Milan, Italy"},{"name":"Centro InterUniversitario sulle Malattie Neurodegenerative, Universit\u00e0 degli Studi di Firenze, Milano, Genova e Roma Tor Vergata"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Poletti","sequence":"additional","affiliation":[{"name":"Sezione di Biomedicina e Endocrinologia, Dipartimento di Scienze Farmacologiche e Biomolecolari (DiSFeB), Centro di Eccellenza sulle Malattie Neurodegenerative, Universit\u00e0 degli Studi di Milano, 20133 Milan, Italy"},{"name":"Centro InterUniversitario sulle Malattie Neurodegenerative, Universit\u00e0 degli Studi di Firenze, Milano, Genova e Roma Tor Vergata"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"288","published-online":{"date-parts":[[2013,11,20]]},"reference":[{"key":"2021111818173432700_B1","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nrn1971","article-title":"Molecular biology of amyotrophic lateral sclerosis: insights from genetics","volume":"7","author":"Pasinelli","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"2021111818173432700_B2","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nrn3430","article-title":"The changing scene of amyotrophic lateral sclerosis","volume":"14","author":"Robberecht","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"2021111818173432700_B3","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.3181\/0903-MR-104","article-title":"Immature copper-zinc superoxide dismutase and familial amyotrophic lateral sclerosis","volume":"234","author":"Seetharaman","year":"2009","journal-title":"Exp. Biol. Med."},{"key":"2021111818173432700_B4","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1089\/ars.2007.1760","article-title":"Amyotrophic lateral sclerosis: from current developments in the laboratory to clinical implications","volume":"10","author":"Cozzolino","year":"2008","journal-title":"Antioxid. Redox Signaling"},{"key":"2021111818173432700_B5","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2011.09.010","article-title":"A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD","volume":"72","author":"Renton","year":"2011","journal-title":"Neuron"},{"key":"2021111818173432700_B6","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","article-title":"Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS","volume":"72","author":"DeJesus-Hernandez","year":"2011","journal-title":"Neuron"},{"key":"2021111818173432700_B7","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00401-011-0911-2","article-title":"p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND\/ALS","volume":"122","author":"Al-Sarraj","year":"2011","journal-title":"Acta Neuropathol."},{"key":"2021111818173432700_B8","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.neuron.2013.02.004","article-title":"Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD\/ALS","volume":"77","author":"Ash","year":"2013","journal-title":"Neuron"},{"key":"2021111818173432700_B9","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.neuron.2013.02.009","article-title":"RANTing about C9orf72","volume":"77","author":"Lashley","year":"2013","journal-title":"Neuron"},{"key":"2021111818173432700_B10","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00401-013-1088-7","article-title":"hnRNP A3 binds to GGGGCC repeats and is a constituent of p62-positive\/TDP43-negative inclusions in the hippocampus of patients with C9orf72 mutations","volume":"125","author":"Mori","year":"2013","journal-title":"Acta Neuropathol."},{"key":"2021111818173432700_B11","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s00401-012-0970-z","article-title":"Pattern of ubiquilin pathology in ALS and FTLD indicates presence of C9ORF72 hexanucleotide expansion","volume":"123","author":"Brettschneider","year":"2012","journal-title":"Acta Neuropathol."},{"key":"2021111818173432700_B12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.pneurobio.2011.09.009","article-title":"Alteration of protein folding and degradation in motor neuron diseases: implications and protective functions of small heat shock proteins","volume":"97","author":"Carra","year":"2012","journal-title":"Prog. Neurobiol."},{"key":"2021111818173432700_B13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.pneurobio.2011.10.001","article-title":"Dysfunction of constitutive and inducible ubiquitin-proteasome system in amyotrophic lateral sclerosis: implication for protein aggregation and immune response","volume":"97","author":"Bendotti","year":"2012","journal-title":"Prog. Neurobiol."},{"key":"2021111818173432700_B14","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1126\/science.1232927","article-title":"The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD\/ALS","volume":"339","author":"Mori","year":"2013","journal-title":"Science"},{"key":"2021111818173432700_B15","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1093\/hmg\/ddm110","article-title":"Mutation of SOD1 in ALS: a gain of a loss of function","volume":"16","author":"Sau","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"2021111818173432700_B16","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1093\/hmg\/ddq257","article-title":"The small heat shock protein B8 (HspB8) promotes autophagic removal of misfolded proteins involved in amyotrophic lateral sclerosis (ALS)","volume":"19","author":"Crippa","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"2021111818173432700_B17","doi-asserted-by":"crossref","first-page":"958","DOI":"10.4161\/auto.6.7.13042","article-title":"A role of small heat shock protein B8 (HspB8) in the autophagic removal of misfolded proteins responsible for neurodegenerative diseases","volume":"6","author":"Crippa","year":"2010","journal-title":"Autophagy"},{"key":"2021111818173432700_B18","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1471-4159.2011.07298.x","article-title":"Muscle cells and motoneurons differentially remove mutant SOD1 causing familial amyotrophic lateral sclerosis","volume":"118","author":"Onesto","year":"2011","journal-title":"J. Neurochem."},{"key":"2021111818173432700_B19","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1042\/BC20100093","article-title":"Dysregulation of axonal transport and motorneuron diseases","volume":"103","author":"Sau","year":"2011","journal-title":"Biol. Cell"},{"key":"2021111818173432700_B20","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s10863-011-9394-z","article-title":"SOD1 and mitochondria in ALS: a dangerous liaison","volume":"43","author":"Carri","year":"2011","journal-title":"J. Bioenerg. Biomembr."},{"key":"2021111818173432700_B21","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pneurobio.2011.06.003","article-title":"Mitochondrial dysfunction in ALS","volume":"97","author":"Cozzolino","year":"2012","journal-title":"Prog. Neurobiol."},{"key":"2021111818173432700_B22","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1093\/hmg\/ddq202","article-title":"ALS-linked mutant SOD1 damages mitochondria by promoting conformational changes in Bcl-2","volume":"19","author":"Pedrini","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"2021111818173432700_B23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/978-1-61779-328-8_2","article-title":"In\u00a0vivo and in\u00a0vitro determination of cell death markers in neurons","volume":"793","author":"Naniche","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"2021111818173432700_B24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2009.09.029","article-title":"The evidence for altered RNA metabolism in amyotrophic lateral sclerosis (ALS)","volume":"288","author":"Strong","year":"2010","journal-title":"J. Neurol. Sci."},{"key":"2021111818173432700_B25","doi-asserted-by":"crossref","first-page":"R46","DOI":"10.1093\/hmg\/ddq137","article-title":"TDP-43 and FUS\/TLS: emerging roles in RNA processing and neurodegeneration","volume":"19","author":"Lagier-Tourenne","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"2021111818173432700_B26","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.brainres.2009.09.105","article-title":"Tar DNA binding protein of 43\u00a0kDa (TDP-43), 14-3-3 proteins and copper\/zinc superoxide dismutase (SOD1) interact to modulate NFL mRNA stability. Implications for altered RNA processing in amyotrophic lateral sclerosis (ALS)","volume":"1305","author":"Volkening","year":"2009","journal-title":"Brain Res."},{"key":"2021111818173432700_B27","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1471-4159.2009.06383.x","article-title":"TDP-43 is recruited to stress granules in conditions of oxidative insult","volume":"111","author":"Colombrita","year":"2009","journal-title":"J. Neurochem."},{"key":"2021111818173432700_B28","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1098\/rstb.2011.0409","article-title":"Different anti-aggregation and pro-degradative functions of the members of the mammalian sHSP family in neurological disorders","volume":"368","author":"Carra","year":"2013","journal-title":"Philos. Trans. R. Soc. London Ser. B"},{"key":"2021111818173432700_B29","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4161\/auto.19496","article-title":"Guidelines for the use and interpretation of assays for monitoring autophagy","volume":"8","author":"Klionsky","year":"2012","journal-title":"Autophagy"},{"key":"2021111818173432700_B30","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/cm.10057","article-title":"Cytoplasmic dynein\/dynactin mediates the assembly of aggresomes","volume":"53","author":"Johnston","year":"2002","journal-title":"Cell Motil. Cytoskeleton"},{"key":"2021111818173432700_B31","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0962-8924(00)01852-3","article-title":"Aggresomes, inclusion bodies and protein aggregation","volume":"10","author":"Kopito","year":"2000","journal-title":"Trends Cell Biol."},{"key":"2021111818173432700_B32","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1096\/fj.01-1035fje","article-title":"Androgen receptor with elongated polyglutamine tract forms aggregates that alter axonal trafficking and mitochondrial distribution in motor neuronal processes","volume":"16","author":"Piccioni","year":"2002","journal-title":"FASEB J."},{"key":"2021111818173432700_B33","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1093\/hmg\/ddl110","article-title":"Pharmacologic and genetic inhibition of hsp90-dependent trafficking reduces aggregation and promotes degradation of the expanded glutamine androgen receptor without stress protein induction","volume":"15","author":"Thomas","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"2021111818173432700_B34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yfrne.2004.03.001","article-title":"The polyglutamine tract of androgen receptor: from functions to dysfunctions in motor neurons","volume":"25","author":"Poletti","year":"2004","journal-title":"Front. Neuroendocrinol."},{"key":"2021111818173432700_B35","doi-asserted-by":"crossref","first-page":"237","DOI":"10.4161\/auto.5407","article-title":"HspB8 and Bag3: a new chaperone complex targeting misfolded proteins to macroautophagy","volume":"4","author":"Carra","year":"2008","journal-title":"Autophagy"},{"key":"2021111818173432700_B36","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1074\/jbc.M706304200","article-title":"HspB8 chaperone activity toward poly(Q)-containing proteins depends on its association with Bag3, a stimulator of macroautophagy","volume":"283","author":"Carra","year":"2008","journal-title":"J. Biol. Chem."},{"key":"2021111818173432700_B37","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cub.2009.11.022","article-title":"Chaperone-assisted selective autophagy is essential for muscle maintenance","volume":"20","author":"Arndt","year":"2010","journal-title":"Curr. Biol."},{"key":"2021111818173432700_B38","doi-asserted-by":"crossref","first-page":"290","DOI":"10.4161\/auto.5524","article-title":"Altered macroautophagy in the spinal cord of SOD1 mutant mice","volume":"4","author":"Li","year":"2008","journal-title":"Autophagy"},{"key":"2021111818173432700_B39","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.neuron.2006.09.018","article-title":"ALS: a disease of motor neurons and their nonneuronal neighbors","volume":"52","author":"Boill\u00e9e","year":"2006","journal-title":"Neuron"},{"key":"2021111818173432700_B40","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S1474-4422(11)70015-1","article-title":"Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease","volume":"10","author":"Philips","year":"2011","journal-title":"Lancet Neurol."},{"key":"2021111818173432700_B41","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/brain\/aws339","article-title":"Oligodendrocyte dysfunction in the pathogenesis of amyotrophic lateral sclerosis","volume":"136","author":"Philips","year":"2013","journal-title":"Brain"},{"key":"2021111818173432700_B42","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1523\/JNEUROSCI.20-07-02534.2000","article-title":"Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases","volume":"20","author":"Frey","year":"2000","journal-title":"J. Neurosci."},{"key":"2021111818173432700_B43","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.expneurol.2003.10.004","article-title":"Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man","volume":"185","author":"Fischer","year":"2004","journal-title":"Exp. Neurol."},{"key":"2021111818173432700_B44","doi-asserted-by":"crossref","first-page":"19546","DOI":"10.1073\/pnas.0609411103","article-title":"Gene transfer demonstrates that muscle is not a primary target for non-cell-autonomous toxicity in familial amyotrophic lateral sclerosis","volume":"103","author":"Miller","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021111818173432700_B45","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1179\/174313208X281235","article-title":"Local expression of mIgf-1 modulates ubiquitin, caspase and CDK5 expression in skeletal muscle of an ALS mouse model","volume":"30","author":"Dobrowolny","year":"2008","journal-title":"Neurol. Res."},{"key":"2021111818173432700_B46","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jns.2008.09.030","article-title":"Amyotrophic lateral sclerosis linked to a novel SOD1 mutation with muscle mitochondrial dysfunction","volume":"276","author":"Corti","year":"2009","journal-title":"J. Neurol. Sci."},{"key":"2021111818173432700_B47","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1093\/hmg\/ddq106","article-title":"Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice","volume":"19","author":"Wong","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"2021111818173432700_B48","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.cmet.2008.09.002","article-title":"Skeletal muscle is a primary target of SOD1G93A-mediated toxicity","volume":"8","author":"Dobrowolny","year":"2008","journal-title":"Cell Metab."},{"key":"2021111818173432700_B49","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1083\/jcb.200407021","article-title":"Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model","volume":"168","author":"Dobrowolny","year":"2005","journal-title":"J. Cell Biol."},{"key":"2021111818173432700_B50","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1126\/science.1086137","article-title":"Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model","volume":"301","author":"Kaspar","year":"2003","journal-title":"Science"},{"key":"2021111818173432700_B51","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1113\/jphysiol.2009.169748","article-title":"Motoneuron survival is promoted by specific exercise in a mouse model of amyotrophic lateral sclerosis","volume":"587","author":"Deforges","year":"2009","journal-title":"J. Physiol."},{"key":"2021111818173432700_B52","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1038\/mt.2008.216","article-title":"Mesenchymal stem cells as trojan horses for GDNF delivery in ALS","volume":"16","author":"Kaspar","year":"2008","journal-title":"Mol. Ther."},{"key":"2021111818173432700_B53","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/nature02261","article-title":"Protein folding and misfolding","volume":"426","author":"Dobson","year":"2003","journal-title":"Nature"},{"key":"2021111818173432700_B54","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.phrs.2011.12.001","article-title":"The anabolic\/androgenic steroid nandrolone exacerbates gene expression modifications induced by mutant SOD1 in muscles of mice models of amyotrophic lateral sclerosis","volume":"65","author":"Galbiati","year":"2012","journal-title":"Pharmacol. Res."},{"key":"2021111818173432700_B55","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1152\/physiolgenomics.00017.2007","article-title":"Gene profiling of skeletal muscle in an amyotrophic lateral sclerosis mouse model","volume":"32","author":"Gonzalez de Aguilar","year":"2008","journal-title":"Physiol. Genomics"}],"container-title":["Biochemical Society Transactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/biochemsoctrans\/article-pdf\/41\/6\/1598\/434085\/bst0411598.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/biochemsoctrans\/article-pdf\/41\/6\/1598\/434085\/bst0411598.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T19:23:17Z","timestamp":1637263397000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/biochemsoctrans\/article\/41\/6\/1598\/68095\/Motoneuronal-and-muscle-selective-removal-of-ALS"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,20]]},"references-count":55,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2013,11,20]]},"published-print":{"date-parts":[[2013,12,1]]}},"URL":"https:\/\/doi.org\/10.1042\/bst20130118","relation":{},"ISSN":["0300-5127","1470-8752"],"issn-type":[{"value":"0300-5127","type":"print"},{"value":"1470-8752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,20]]}}}